List of Free Cancer Medicines for Children Below 18 Years in Nepal
Free Cancer Medicines for Children Below 18 Years in Nepal: Patan Hospital, Kanti Children’s Hospital and Bhaktapur Cancer Hospital, BP Koirala Memorial Cancer Hospital
Under the World Health Organization (WHO) GPACCM programme, a list of cancer medicines is provided for children below 18 years receiving treatment at designated hospitals in Nepal.
The medicines, delivered through UNICEF’s procurement services, will support treatment for children at four hospitals: Bhaktapur Cancer Hospital, Kanti Children’s Hospital, Patan Academy of Health Sciences, and BP Koirala Memorial Cancer Hospital. These facilities have met rigorous standards for safe handling and administration of cancer medicines, ensuring quality care for young patients.
List of Cancer Medicines free for children
The provided list includes the following 33 medicine available in Patan Hospital
- Actinomycin-D 500 mcg injection
- Allopurinol 100 mg tablet
- Bleomycin 15,000 IU injection
- Carboplatin 150 mg injection
- Carboplatin 450 mg injection
- Cisplatin 50 mg injection
- Cyclophosphamide 500 mg injection
- Cyclophosphamide 50 mg tablet
- Cytarabine 1,000 mg injection
- Cytarabine 100 mg injection
- Dacarbazine 100 mg injection
- Dasatinib 20 mg tablet
- Daunorubicin 20 mg injection
- Dexamethasone 2 mg tablet
- Dexamethasone syrup
- Doxorubicin 10 mg injection
- Doxorubicin 50 mg injection
- Hydroxycarbamide 500 mg tablet
- Ifosfamide 1 g injection
- Ifosfamide 500 mg injection
- L-Asparaginase 10,000 IU injection
- Mercaptopurine 50 mg tablet (25 tablets listed)
- Mesna 100 mg injection
- Methotrexate 1,000 mg injection
- Methotrexate 2.5 mg tablet
- Methotrexate 250 mg injection
- Methotrexate 50 mg injection
- Pegfilgrastim 6 mg injection
- Prednisolone 5 mg tablet
- Rituximab 100 mg injection
- Tioguanine 40 mg tablet
- Vinblastine 10 mg injection
- Vincristine 1 mg injection
- Allopurinol — 100 mg — Tablet
- Allopurinol — 300 mg — Tablet
- Arsenic trioxide — 2 mg/mL — Solution for injection
- Arsenic trioxide — 1 mg/mL — Solution for injection
- Asparaginase — 10,000 IU — Powder for concentrate for solution for infusion
- Bleomycin — 15,000 IU — Powder for injection
- Calcium folinate — 3 mg/mL — Solution for injection
- Calcium folinate — 5 mg/mL — Solution for injection
- Calcium folinate — 10 mg/mL — Solution for injection
- Calcium folinate — 5 mg — Tablet
- Calcium folinate — 15 mg — Tablet
- Carboplatin — 10 mg/mL — Concentrate for solution for injection
- Carboplatin — 10 mg/mL — Concentrate for solution for injection
- Cisplatin — 1 mg/mL — Concentrate for solution for injection
- Cisplatin — 1 mg/mL — Concentrate for solution for injection
- Cisplatin — 1 mg/mL — Concentrate for solution for injection
- Cyclophosphamide — 50 mg — Tablet
- Cyclophosphamide — 500 mg — Powder for solution for injection
- Cyclophosphamide — 1 g — Powder for solution for injection
- Cytarabine — 100 mg — Powder for injection
- Cytarabine — 20 mg/mL — Solution for injection
- Cytarabine — 100 mg/mL — Solution for injection
- Dacarbazine — 100 mg — Powder for solution for injection
- Dactinomycin — 500 mcg — Powder for solution for injection
- Dasatinib — 20 mg — Tablet
- Dasatinib — 50 mg — Tablet
- Dasatinib — 70 mg — Tablet
- Daunorubicin — 20 mg — Powder for solution for injection
- Daunorubicin — 50 mg — Powder for injection
- Dexamethasone — 2 mg — Tablet
- Dexamethasone — 4 mg — Tablet
- Dexamethasone — 2 mg/5 mL — Oral solution
- Doxorubicin — 10 mg/5 mL — Concentrate for solution for injection
- Doxorubicin — 50 mg/25 mL — Concentrate for solution for injection
- Doxorubicin — 50 mg — Powder for injection
- Doxorubicin — 10 mg — Powder for injection
- Etoposide — 50 mg — Soft capsule
- Etoposide — 20 mg/mL — Concentrate for solution for injection or infusion
- Filgrastim — 30 MU/0.5 mL — Solution for injection
- Filgrastim — 30 MU/mL — Solution for injection
- Fluorouracil — 25 mg/mL — Solution for injection or infusion
- Fluorouracil — 50 mg/mL — Solution for injection or infusion
- Fluorouracil — 50 mg/mL — Solution for injection or infusion
- Hydroxycarbamide — 500 mg — Hard capsule
- Hydroxycarbamide — 100 mg — Tablet
- Hydroxycarbamide — 200 mg — Tablet
- Hydroxycarbamide — 1000 mg — Tablet, scored
- Ifosfamide — 500 mg — Powder for solution for injection
- Ifosfamide — 1 g — Powder for solution for injection
- Ifosfamide — 2 g — Powder for solution for injection
- Imatinib — 100 mg — Tablet
- Imatinib — 400 mg — Tablet
- Irinotecan — 20 mg/mL — Concentrate for solution for injection
- Mercaptopurine — 50 mg — Tablet
- Mesna — 100 mg/mL — Solution for injection
- Methotrexate — 2.5 mg — Tablet
- Methotrexate — 25 mg/mL — Solution for injection
- Methotrexate — 25 mg/mL — Solution for injection
- Methotrexate — 25 mg/mL — Solution for injection
- Pegaspargase — 750 U/mL — Powder for solution for injection
- Pegfilgrastim — 6 mg/0.6 mL — Solution for injection
- Prednisolone — 5 mg — Tablet
- Prednisolone — 5 mg — Soluble tablet
- Prednisolone — 25 mg — Tablet
- Prednisolone — 10 mg — Soluble tablet
- Prednisolone — 10 mg/mL — Oral solution
- Procarbazine — 50 mg — Capsule
- Rituximab — 10 mg/mL — Concentrate for solution for injection
- Tioguanine — 40 mg — Tablet
- Tretinoin — 10 mg — Soft capsule
- Vinblastine — 1 mg/mL — Solution for injection
- Vinblastine — 10 mg — Powder for solution for injection
- Vincristine — 1 mg/mL — Solution for injection
Hospitals Where Parents Can Enquire
- Patan Hospital
- Kanti Children’s Hospital
- Bhaktapur Cancer Hospital
- BP Koirala Memorial Cancer Hospital
Parents or guardians should contact the paediatric oncology or relevant cancer-treatment department at these hospitals to determine whether their child qualifies for the programme and whether the prescribed medicine is currently available.
Important Information
- Eligibility and required documents should be confirmed with the hospital.
- Medicine availability may vary by hospital and time.
- Cancer medicines must be used only under the supervision of qualified healthcare professionals.
- Do not change or discontinue prescribed cancer treatment without consulting the treating oncologist.
Access to essential cancer medicines can help reduce the financial burden on families and support treatment for children with cancer.
Disclaimer: This article is based on the medicine list supplied for preparation. The current programme status, participating hospitals, eligibility criteria and availability of individual medicines should be verified with the relevant hospitals or official programme authorities.
Source: Medicine list provided for the WHO GPACCM programme.
